| Literature DB >> 27167372 |
Ramin Heshmat1, Mostafa Qorbani2,3, Amir Eslami Shahr Babaki1, Shirin Djalalinia4,5, Asal Ataei-Jafari6, Mohammad Esmaeil Motlagh7, Gelayol Ardalan1, Tahereh Arefirad8, Fatemeh Rezaei9, Hamid Asayesh10, Roya Kelishadi11.
Abstract
Metabolic syndrome (MetS) and its contributing factors are considered important health problems in the pediatric age group. This study was designed to assess the joint association of ST and PA with cardiometabolic risk factors among Iranian adolescents. A representative sample of 5625 (50.2% boys) school students with a mean age of 14.73 (SD: 2.41) were selected through multistage random cluster sampling method from urban and rural areas of 27 provinces in Iran. ST and PA were assessed by self-administered validated questionnaires. Anthropometric measures (height, weight and waist circumference (WC)) and MetS components (abdominal obesity, elevated blood pressure (BP), low high-density lipoprotein cholesterol (HDL-C), elevated triglycerides (TG) and high fasting blood sugar (FBG)) were measured according to standardized protocols. MetS was defined according to the Adult Treatment Panel III criteria modified for the pediatric age group. Moreover, elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-C), and generalized obesity were considered as other cardiometabolic risk factors. Students with high ST levels had significantly higher body mass index z-score (BMI z-score), WC, TG, LDL-C, and BP as well as lower HDL-C level; whereas those with high PA levels had significantly higher HDL-C levels as well as lower BMI z-score, TC, and BP. Adolescents with low PA/ high ST levels had significantly higher BMI, WC, LDL-C levels, as well as higher SBP and DBP compared to their other counterparts. In Multivariate model, joint effect of low PA/ high ST (compared to the high PA/low ST group) increased the odds of overweight, abdominal obesity and low HDL-C and decreased the odds of elevated TC. The findings of this study showed that joint association of high ST and low PA have direct association with abdominal obesity, overweight and low HDL-C and indirect association with elevated TC.Entities:
Mesh:
Year: 2016 PMID: 27167372 PMCID: PMC4864273 DOI: 10.1371/journal.pone.0154502
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic characteristics and anthropometric measures according to sexes: The CASPIAN III study.
| Boys | Girls | Total | ||
|---|---|---|---|---|
| Age (year) | 14.69 (2.45) | 14.76(2.37) | 14.73(2.41) | 0.24 |
| Height (cm) | 151.80(11.64) | 156.54(15.59) | 154.16(13.95) | <0.001 |
| Weight (Kg) | 45.93(13.21) | 48.42(16.53) | 47.17(15.00) | <0.001 |
| BMI z-score | 0.46 (1.0) | -0.46 (1.0) | 0(1.0) | 0.001 |
| WC (cm) | 67.60(22.18) | 69.85(18.99) | 68.72(20.69) | <0.001 |
| WHtR | 0.44 (0.14) | 0.45(0.12) | 0.44(0.12) | 0.73 |
| Obesity; n (%) | 286 (10.1) | 215 (7.7) | 501 (8.9) | 0.001 |
| Overweight; n (%) | 265 (9.4) | 186 (6.6) | 451 (8.0) | <0.001 |
| Abdominal obesity; n (%) | 415 (14.7) | 471 (16.9) | 886 (15.8) | 0.02 |
| Father’s education; n (%) | 0.48 | |||
| <6y | 1138 (41.4) | 1153 (42.6) | 2291 (42.0) | |
| 6–9y | 662 (24.1) | 668 (24.7) | 1330 (24.4) | |
| 10–12y | 685 (24.9) | 626 (23.2) | 1311 (24.0) | |
| >12y | 263 (9.6) | 257 (9.5) | 520 (9.5) | |
| Mother’s education; n (%) | 0.50 | |||
| <6y | 1489 (53.6) | 1515 (55.6) | 3004 (54.6) | |
| 6–9y | 580 (20.9) | 548 (20.1) | 1128 (20.5) | |
| 10–12y | 570 (20.5) | 534 (19.6) | 1104 (20.1) | |
| >12y | 141 (5.1) | 128 (4.7) | 269 (4.9) | |
| ST Activity(hours/day) | ||||
| Watching TV; n (%) | 0.65 | |||
| <2 | 991 (35.6) | 940 (35.0) | 1931 (35.3) | |
| ≥2 | 1790 (64.4) | 1742 (65.0) | 3532 (64.7) | |
| Working with computer; n (%) | <0.001 | |||
| <2 | 2372 (84.3) | 2803 (76.5) | 4453 (80.4) | |
| ≥2 | 443 (15.7) | 641 (23.5) | 1084 (19.6) | |
| ST; n (%) | <0.001 | |||
| Low | 1576 (56.8) | 1370 (51.3) | 2946 (54.1) | |
| High | 1199 (43.2) | 1303 (48.7) | 2502 (45.9) | |
| PA; n (%) | <0.001 | |||
| Low | 2491 (88.4) | 2224 (81.3) | 4715 (84.9) | |
| High | 327 (11.6) | 510 (18.7) | 837 (15.1) | |
| Joint associations of PA & ST; n (%) | <0.001 | |||
| High PA & Low ST | 208 (7.5) | 262 (9.8) | 470 (8.6) | |
| High PA & High ST | 114 (4.1) | 235 (8.8) | 349 (6.4) | |
| Low PA & Low ST | 1368 (49.3) | 1107 (41.4) | 2475 (45.5) | |
| Low PA & High ST | 1083 (39.1) | 1068 (40.0) | 2151 (39.5) | |
| Family history; n (%) | ||||
| HTN | 1134 (51.4) | 1039 (47.7) | 2173 (49.5) | 0.02 |
| Dyslipidemia | 909 (42.7) | 859 (40.3) | 1768 (41.5) | 0.13 |
| DM | 831 (39.1) | 717 (34.2) | 1548 (36.7) | 0.001 |
| Obesity | 876 (42.8) | 747 (37.1) | 1623 (40.0) | <0.001 |
| Type of home; n (%) | 0.63 | |||
| Rented home | 531 (19.5) | 531 (20.0) | 1062 (19.8) | |
| Owned home | 2193 (80.5) | 2119 (80.0) | 4312 (80.2) | |
| Private car; n (%) | 0.83 | |||
| Yes | 1373 (49.8) | 1340 (49.5) | 2713 (49.7) | |
| No | 1382 (50.2) | 1366 (50.5) | 2748 (50.3) | |
| SES; n (%) | 0.76 | |||
| Low | 527 (19.6) | 525 (20.0) | 1052 (19.8) | |
| Intermediate | 1047 (38.9) | 1038 (39.5) | 2085 (39.2) | |
| High | 1115 (41.5) | 1063 (40.5) | 2178 (41.0) |
Data are means (SD) unless indicated otherwise.
BMI; Body Mass Index, WC; Waist Circumference, HTN; Hypertension, DM; Diabetes Mellitus, ST; Screen Time, PA; Physical Activity, SES; Socioeconomic status.
¶ Low ST: <2 hours/day; high ST: ≥2 hours/day
£Low PA: 0–2 days/week; high PA: 3–7 days / week
* Statistically significant
Mean (SD) of cardiometabolic values according to ST, PA and joint associations of ST and PA categories: The CASPIAN III study.
| ST | PA | Joint association of PA and ST | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Low | High | p-value | Low | High | p-value | High PA/ Low ST | High PA & High ST | Low PA & Low ST | Low PA/ High ST | P-value | |
| BMI z-score | -0.07 (1.0) | 0.09 (1.0) | <0.001 | 0.01 (1.0) | - 0.07 (1.0) | 0.03 | -0.15 (1.0)a | 0.07 (1.0)b | -0.05 (1.0)ab | 0.09 (1.0)bc | <0.001 |
| WC (cm) | 67.9 (22.8) | 69.7 (18.5) | 0.002 | 68.8(20.4) | 68.3(22.8) | 0.03 | 67.8(28.9)ab | 69.4(10.7)ab | 67.9(21.4)b | 69.7(19.4)a | 0.023 |
| WHtR | 0.45 (0.15) | 0.45(0.11) | 0.96 | 0.44(0.13) | 0.45 (0.15) | 0.67 | 0.45(0.19) | 0.44(0.05) | 0.44(0.14) | 0.45(0.11) | 0.851 |
| FBG (mg/dl) | 87.8 (13.4) | 87.5(14.6) | 0.45 | 87.5(14.1) | 88.6 (12.6) | 0.06 | 88.0(12.5) | 89.5(12.9) | 87.8(13.6) | 87.2(14.8) | 0.064 |
| TG (mg/dl) | 91.4 (38.9) | 94.2(42.8) | 0.02 | 92.8 (41.1) | 91.9(39.8) | 0.59 | 90.6(38.7) | 93.8(41.6) | 91.6(39.0) | 94.3(43.0) | 0.137 |
| HDL-C (mg/dl) | 47.1 (14.5) | 45.3(14.3) | <0.001 | 45.9(14.1) | 48.5(14.9) | <0.001 | 47.9(14.6)a | 49.4(15.7) a | 46.9(14.5) a | 44.7(13.8)b | <0.001 |
| TC (mg/dl) | 148.2 (31.4) | 149.1(32.3) | 0.36 | 151.3(33.3) | 147.9(31.4) | 0.01 | 151.7(34.1)a | 151.4(32.5)ab | 147.5(30.8)b | 148.7(32.2)ab | 0.035 |
| LDL-C (mg/dl) | 82.9 (26.9) | 85.7(27.8) | 0.005 | 84.2(27.4) | 84.1(27.3) | 0.91 | 84.0 (27.6)ab | 84.1(27.1)ab | 82.7(26.8)b | 85.9(27.9)a | 0.025 |
| SBP (mmHg) | 102.6 (13.8) | 103.9(14.0) | <0.001 | 103.3(13.9) | 102.2(14.1) | 0.04 | 101.2(14.1)a | 103.6(13.9)ab | 102.8(13.7)a | 104.0(14.1)b | 0.001 |
| DBP (mmHg) | 65.3 (10.8) | 66.2(10.6) | 0.001 | 65.8(10.6) | 64.8(11.2) | 0.01 | 64.6(11.5)a | 65.2(10.9)ab | 65.4 (10.6)a | 66.4(10.6)b | 0.001 |
Data are mean(SD),BMI; Body Mass Index, WC; Waist Circumference, WHtR; Waist to Height Ratio, FBS; Fasting Blood Sugar, TG; Triglycerides, HDL-C; High Density Lipoprotein-Cholesterol, TC; Total Cholesterol, LDL-C; Low-Density Lipoprotein Cholesterol, SBP; Systolic Blood Pressure; DBP; diastolic Blood Pressure, ST; Screen Time, PA; Physical Activity.
For joint association of PA and ST, within rows, means with different superscript letters are significantly different (by Tukey’s post hoc tests).
¶ Low ST: <2 hours/day; high ST: ≥2 hours/day
£Low PA: 0–2 days/week; high PA: 3–7 days / week
* Statistically significant
Prevalence of cardiometabolic risk factors according to ST, PA and joint associations of ST and PA categories: The CASPIAN III study.
| ST | PA | Joint association of ST and PA | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Low | High | Low | High | High PA/ Low ST | High PA & High ST | Low PA & Low ST | Low PA/ High ST | ||||
| Abdominal obesity | 445 (15.1) | 416 (16.7) | 0.17 | 756 (16.1) | 123 (14.7) | 0.33 | 66 (14.0) | 56 (16.0) | 379 (15.3) | 360 (16.8) | 0.384 |
| Elevated SBP | 96(3.5) | 94 (4.0) | 0.37 | 168 (3.8) | 28 (3.6) | 0.9 | 12 (2.8) | 16 (5.0) | 84 (3.7) | 77 (3.8) | 0.464 |
| Elevated DBP | 81 (2.9) | 76 (3.2) | 0.57 | 128 (2.9) | 29 (3.7) | 0.26 | 16 (3.6) | 13 (3.9) | 65 (2.8) | 63 (3.1) | 0.582 |
| Elevated BP | 140 (5.3) | 141 (6.2) | 0.16 | 236 (5.5) | 47 (6.2) | 0.44 | 23 (5.4) | 24 (7.7) | 117 (5.2) | 117 (6.0) | 0.321 |
| Elevated TG | 172(7.1) | 187 (9.2) | 0.01 | 310 (8.1) | 54 (7.8) | 0.88 | 31 (7.9) | 22 (7.7) | 141 (7.0) | 165 (9.4) | 0.051 |
| Elevated FBG | 356(15.0) | 317(16.2) | 0.27 | 561(15.0) | 119(17.4) | 0.12 | 64 (16.5) | 53 (19.0) | 291 (14.6) | 264 (15.8) | 0.255 |
| Low HDL-C | 694(33.5) | 651(36.9) | 0.03 | 1210 (36.4) | 159 (27.2) | <0.001 | 98 (29.8) | 59 (24.4) | 596 (34.3) | 592 (38.9) | <0.001 |
| Elevated TC | 139 (5.7) | 127 (6.0) | 0.61 | 207 (5.3) | 60 (8.7) | .001 | 37 (9.4) | 23 (8.1) | 102 (5.0) | 104 (5.7) | 0.002 |
| Elevated LDL-C | 130 (5.0) | 130 (6.9) | 0.03 | 220 (5.9) | 35 (5.0) | 0.45 | 20 (4.9) | 20 (5.5) | 105 (5.0) | 124 (7.1) | 0.117 |
| General obesity | 257 (8.7) | 230 (9.2) | 0.57 | 427 (9.1) | 70 (8.4) | 0.56 | 39 (8.3) | 31 (8.9) | 218 (8.8) | 199 (9.3) | 0.908 |
| Overweight | 217 (7.4) | 224 (9.0) | 0.04 | 390 (8.3) | 60 (7.2) | 0.30 | 30 (6.4) | 29 (8.3) | 187 (7.6) | 195 (9.1) | 0.135 |
| Number of Mets components | 0.04 | 0.46 | 0.301 | ||||||||
| 0 | 840 (46.2) | 630 (40.9) | 1259 (43.3) | 241 (46.6) | 143 (48.3) | 92 (43.6) | 697 (45.8) | 537 (40.4) | |||
| 1 | 695 (38.2) | 631 (40.9) | 1156 (39.8) | 195 (37.7) | 111 (37.5) | 80 (37.9) | 583 (38.3) | 551 (41.4) | |||
| 2 | 216 (11.9) | 213 (13.8) | 367 (12.6) | 67 (13.0) | 34 (11.5) | 33 (15.6) | 182 (12.0) | 180 (13.5) | |||
| 3 | 58 (3.2) | 57 (3.7) | 105 (3.6) | 11 (2.1) | 6 (2.0) | 5 (2.4) | 52 (3.4) | 52 (3.9) | |||
| 4 | 10 (0.6) | 11 (0.7) | 18 (0.6) | 3 (0.6) | 2 (0.7) | 1 (0.5) | 8 (0.5) | 10 (0.8) | |||
| Having MetS | 68 (3.7) | 68 (4.4) | 0.34 | 123 (4.2) | 14 (2.7) | 0.11 | 8 (2.7) | 6 (2.8) | 60 (3.9) | 62 (4.7) | 0.321 |
Data are N (%), BP; Blood Pressure, TG; Triglycerides, FBG; Fasting Blood Glucose, HDL-C; High Density Lipoprotein-Cholesterol, TC; Total Cholesterol, LDL-C; Low-Density Lipoprotein Cholesterol, MetS; Metabolic Syndrome, ST; Screen Time, PA; Physical Activity.
Abdominal obesity: WHtR>0.05; Elevated SBP: systolic BP>90th adjusted by age, sex and height; Elevated DBP: diastolic BP>90th adjusted by age, sex and height; Elevated BP: either systolic or diastolic BP>90th adjusted by age, sex and height; Elevated FBS:>100 mg/dl; Elevated TG:> = 100 mg/dl; Low HDL: <50 mg/dl (except in boys 15–19 years old, that cut-off was <45 mg/dl); Elevated TC:>200 mg/dl; Elevated LDL:>110 mg/dl; Overweight: BMI:85th-95th; Obesity: BMI > 95th; Having MetS: having at least three criteria according to modified ATP III criteria; Low ST: <2 hours/day; high ST: ≥2 hours/day; Low PA: 0–2 days/week; high PA: 3–7 days / week.
* Statistically significant
Odds ratios (95% CI) for cardiometabolic risk factors according to joint associations of ST and PA categories: The CASPIAN III study.
| Joint association of ST and PA | ||||||||
|---|---|---|---|---|---|---|---|---|
| High PA & Low ST | High PA & High ST | Low PA & Low ST | Low PA & High ST | |||||
| OR | CI | OR | CI | OR | CI | |||
| Abdominal obesity | ||||||||
| Model I | 1 | 1.170 | 0.795–1.722 | 1.108 | 0.835–1.469 | 1.234 | 0.929–1.639 | |
| Model II | 1 | 1.133 | 0.769–1.670 | 1.121 | 0.844–1.489 | 1.229 | 0.923–1.636 | |
| Model III | 1 | 1.204 | 0.731–1.984 | 1.283 | 0.892–1.846 | 1.485 | 1.029–2.144 | |
| Elevated BP | ||||||||
| Model I | 1 | 1.455 | 0.805–2.629 | 0.969 | 0.612–1.534 | 1.115 | 0.704–1.766 | |
| Model II | 1 | 1.208 | 0.664–2.199 | 0.906 | 0.569–1.444 | 0.944 | 0.592–1.506 | |
| Model III | 1 | 1.202 | 0.582–2.483 | 1.063 | 0.613–1.844 | 0.991 | 0.567–1.732 | |
| Model IV | 1 | 1.048 | 0.499–2.205 | 1.018 | 0.580–1.784 | 0.897 | 0.507–1.586 | |
| Elevated FBG | ||||||||
| Model I | 1 | 1.191 | 0.797–1.780 | 0.871 | 0.648–1.171 | 0.949 | 0.704–1.280 | |
| Model II | 1 | 1.127 | 0.752–1.689 | 0.913 | 0.678–1.231 | 0.971 | 0.717–1.314 | |
| Model III | 1 | 1.072 | 0.678–1.695 | 0.829 | 0.595–1.155 | 0.918 | 0.656–1.286 | |
| Model IV | 1 | 1.063 | 0.672–1.682 | 0.828 | 0.594–1.153 | 0.912 | 0.651–1.278 | |
| Elevated TG | ||||||||
| Model I | 1 | 0.981 | 0.555–1.732 | 0.876 | 0.584–1.313 | 1.218 | 0.816–1.817 | |
| Model II | 1 | 0.952 | 0.538–1.685 | 0.845 | 0.563–1.270 | 1.157 | 0.772–1.733 | |
| Model III | 1 | 0.663 | 0.315–1.395 | 0.867 | 0.541–1.388 | 1.091 | 0.680–1.750 | |
| Model IV | 1 | 0.586 | 0.274–1.250 | 0.811 | 0.500–1.315 | 0.984 | 0.605–1.598 | |
| Low HDL-C | ||||||||
| Model I | 1 | 0.760 | 0.521–1.108 | 1.228 | 0.950–1.587 | 1.502 | 1.161–1.944 | |
| Model II | 1 | 0.709 | 0.486–1.036 | 1.187 | 0.917–1.536 | 1.400 | 1.078–1.817 | |
| Model III | 1 | 0.766 | 0.492–1.193 | 1.219 | 0.907–1.640 | 1.311 | 0.971–1.771 | |
| Model IV | 1 | 0.748 | 0.480–1.165 | 1.218 | 0.906–1.639 | 1.297 | 0.960–1.753 | |
| Elevated TC | ||||||||
| Model I | 1 | 0.842 | 0.489–1.452 | 0.502 | 0.339–0.744 | 0.584 | 0.394–0.864 | |
| Model II | 1 | 0.896 | 0.518–1.549 | 0.499 | 0.336–0.741 | 0.598 | 0.401–0.891 | |
| Model III | 1 | 0.956 | 0.506–1.808 | 0.500 | 0.318–0.788 | 0.647 | 0.409–1.023 | |
| Model IV | 1 | 0.908 | 0.479–1.720 | 0.487 | 0.309–0.768 | 0.615 | 0.388–0.976 | |
| Elevated LDL-C | ||||||||
| Model I | 1 | 1.134 | 0.486–2.644 | 1.039 | 0.567–1.904 | 1.501 | 0.826–2.727 | |
| Model II | 1 | 1.243 | 0.531–2.910 | 1.067 | 0.580–1.963 | 1.645 | 0.898–3.011 | |
| Model III | 1 | 1.583 | 0.557–4.501 | 1.200 | 0.558–2.584 | 1.991 | 0.933–4.248 | |
| Model IV | 1 | 1.542 | 0.542–4.389 | 1.192 | 0.554–2.566 | 1.958 | 0.917–4.180 | |
| Overweight | ||||||||
| Model I | 1 | 1.329 | 0.782–2.259 | 1.199 | 0.805–1.786 | 1.462 | 0.982–2.177 | |
| Model II | 1 | 1.400 | 0.822–2.384 | 1.163 | 0.779–1.736 | 1.452 | 0.972–2.171 | |
| Model III | 1 | 1.577 | 0.813–3.058 | 1.224 | 0.743–2.017 | 1.773 | 1.075–2.923 | |
| General obesity | ||||||||
| Model I | 1 | 1.077 | 0.658–1.764 | 1.067 | 0.748–1.524 | 1.127 | 0.787–1.613 | |
| Model II | 1 | 1.160 | 0.707–1.904 | 1.073 | 0.750–1.535 | 1.181 | 0.822–1.697 | |
| Model III | 1 | 1.222 | 0.629–2.378 | 1.292 | 0.803–2.079 | 1.418 | 0.874–2.302 | |
| Having MetS | ||||||||
| Model I | 1 | 1.054 | 0.360–3.083 | 1.477 | 0.699–3.123 | 1.760 | 0.834–3.717 | |
| Model II | 1 | 0.898 | 0.306–2.638 | 1.410 | 0.664–2.995 | 1.557 | 0.733–3.310 | |
| Model III | 1 | 0.991 | 0.260–3.782 | 1.599 | 0.623–4.101 | 1.571 | 0.606–4.074 | |
| Model IV | 1 | 0.737 | 0.180–3.023 | 1.563 | 0.569–4.292 | 1.536 | 0.552–4.274 | |
BP; Blood Pressure, TG; Triglycerides, FBG; Fasting Blood Glucose, HDL-C; High Density Lipoprotein-Cholesterol, TC; Total Cholesterol, LDL-C; Low-Density Lipoprotein Cholesterol, MetS; Metabolic Syndrome, ST; screen time, PA; physical activity.
Abdominal obesity: WHtR>0.05; Elevated BP: either systolic or diastolic BP>90th adjusted by age, sex and height; Elevated FBS:>100 mg/dl; Elevated TG:> = 100 mg/dl; Low HDL: <50 mg/dl (except in boys 15–19 years old, that cut-off was <45 mg/dl); Elevated TC:>200 mg/dl; Elevated LDL:>110 mg/dl; Overweight: BMI:85th-95th; Obesity: BMI > 95th; Having MetS: having at least three criteria according to modified ATP III criteria; Low ST: <2 hours/day; high ST: ≥2 hours/day; Low PA: 0–2 days/week; high PA: 3–7 days / week.
Model I: crude model; Model II is adjusted for age and gender; Model III adjusted additionally for family history and socio-economic status; Model IV is adjusted additionally for BMI in all abnormalities except obesity.
* Statistically significant